Evidence map›Paper›PMID 33095970›Full record

ArticleTransboundary and emerging diseases2021

Interoperable medical data: The missing link for understanding COVID-19.

Denis C Bauer, Alejandro Metke-Jimenez, Sebastian Maurer-Stroh, Suma Tiruvayipati, Laurence O W Wilson, Yatish Jain, Amandine Perrin, Kate Ebrill, David P Hansen, Seshadri S Vasan

Abstract read
In one paragraph

Article in Transboundary and emerging diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. HL7 FHIR-based tools and initiatives to support clinical research: a scoping review.Journal of the American Medical Informatics Association : JAMIA · 2022
    Article
  7. Review
  8. Article
  9. Data-driven platform for identifying variants of interest in COVID-19 virus.Computational and structural biotechnology journal · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Denis C BauerAustralian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation, Geelong, Australia, Australia.ORCID https://orcid.org/0000-0001-8033-9810
Alejandro Metke-JimenezCommonwealth Scientific and Industrial Research Organisation, Australian e-Health Research Centre, Herston, QLD, Australia.
Sebastian Maurer-StrohAgency for Science Technology and Research, Bioinformatics Institute, Singapore, Singapore.
Suma TiruvayipatiGlobal Initiative on Sharing All Influenza Data (GISAID), Munich, Germany.
Laurence O W WilsonAustralian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation, Geelong, Australia, Australia.
Yatish JainAustralian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation, Geelong, Australia, Australia.
Amandine PerrinBioinformatics and Biostatistics Hub, Department of Computational Biology, Institut Pasteur, USR 3756 CNRS, Paris, France.
Kate EbrillCommonwealth Scientific and Industrial Research Organisation, Australian e-Health Research Centre, Herston, QLD, Australia.
David P HansenCommonwealth Scientific and Industrial Research Organisation, Australian e-Health Research Centre, Herston, QLD, Australia.
Seshadri S VasanAustralian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Geelong, VIC, Australia.ORCID https://orcid.org/0000-0002-7326-3210

Funding

Coalition for Epidemic Preparedness Innovations (S.S.V.)Genome Institute of Singapore (S.T.)Institut Pasteur (A.P.)Temasek Foundation (S.T.); Agency for Science, Technology and Research (S.T.; S.M-S.)
6 · The paper itself

Abstract

Being able to link clinical outcomes to SARS-CoV-2 virus strains is a critical component of understanding COVID-19. Here, we discuss how current processes hamper sustainable data collection to enable meaningful analysis and insights. Following the 'Fast Healthcare Interoperable Resource' (FHIR) implementation guide, we introduce an ontology-based standard questionnaire to overcome these shortcomings and describe patient 'journeys' in coordination with the World Health Organization's recommendations. We identify steps in the clinical health data acquisition cycle and workflows that likely have the biggest impact in the data-driven understanding of this virus. Specifically, we recommend detailed symptoms and medical history using the FHIR standards. We have taken the first steps towards this by making patient status mandatory in GISAID ('Global Initiative on Sharing All Influenza Data'), immediately resulting in a measurable increase in the fraction of cases with useful patient information. The main remaining limitation is the lack of controlled vocabulary or a medical ontology.

Indexed as

COVID-19Influenza, HumanAnimalsGlobal HealthHumansSARS-CoV-2COVID-19genome sequenceGISAIDontologypatient informationSARS-CoV-2

Identifiers

PMID33095970
PMCPMC8359419

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.